Human cystic fibrosis transmembrane conductance regulator gene (CFTR) transcription is tightly regulated by nucleotide sequences upstream of the initiator sequences. Our studies of human CFTR transcription focus on identifying transcription factors bound to an inverted CCAAT consensus or "Y-box element." The human homeodomain CCAAT displacement protein/cut homolog (CDP/cut) can bind to the Y-box element through a cut repeat and homeobox. Analysis of stably transfected cell lines with wild-type and mutant human CFTR-directed reporter genes demonstrates that human histone acetyltransferase GCN5 and transcription factor ATF-1 can potentiate CFTR transcription through the Y-box element. We have found 1) that human CDP/ cut acts as a repressor of CFTR transcription through the Y-box element by competing for the sites of transactivators hGCN5 and ATF-1; 2) that the ability of CDP/cut to repress activities of hGCN5 and ATF-1 activity is contingent on the amount of CDP/cut expression; 3) that histone acetylation may have a role in the regulation of gene transcription by altering the accessibility of the CFTR Y-box for sequence-specific transcription factors; 4) that trichostatin A, an inhibitor of histone deacetylase activity, activates transcription of CFTR through the Y-box element; 5) that the inhibition of histone deacetylase activity leads to an alteration of local chromatin structure requiring an intact Y-box sequence in CFTR; 6) that immunocomplexes of CDP/cut possess an associated histone deacetylase activity; 7) that the carboxyl region of CDP/cut, responsible for the transcriptional repressor function, interacts with the histone deacetylase, HDAC1. We propose that CFTR transcription may be regulated through interactions with factors directing the modification of chromatin and requires the conservation of the inverted CCAAT (Y-box) element of the CFTR promoter.
The gene responsible for cystic fibrosis encodes the cystic fibrosis transmembrane conductance regulator (CFTR) 1 protein (1, 2) . The expression of CFTR is confined primarily to specific epithelial cell types and is ordinarily expressed in low levels. The low levels and cell type-specific expression of CFTR appear to be dictated primarily by sequences upstream of the transcriptional start sites of CFTR which correspond to functional promoter sequences (3, 4) . The elements required for active, cell type-specific CFTR transcription lie in a narrow band of nucleotide sequences, proximal to the multiple transcript initiation (5) . The levels of CFTR transcripts in individual cell types appear to correspond to the ability of specific epithelia to modulate expression of CFTR variably in response to 1) levels of cAMP (6) , 2) the stimulation of protein kinase A and C activities (7) (8) (9) , and 3) phorbol esters (10) likely through signaling pathways or mechanisms that converge ultimately on gene transcription (for review, see Ref. 11) .
The tight transcriptional control of CFTR requires a conserved inverted CCAAT (Y-box) element (12) . Despite the absence of a TATA signal, the human CFTR gene can initiate RNA transcription through multiple, discrete start sites requiring conserved residues within the Y-box. Thus, an intact CCAAT consensus on the opposing strand of the human CFTR appears to be a requirement for accurate transcript initiation (12) . Both basal and cAMP-mediated regulation of CFTR transcription have implicated the Y-box (12) in tandem with a weak CRE nucleotide consensus downstream (13) . CFTR transcription appears to be influenced by additional cis-acting elements, including a site located in the first intron of the human CFTR (14) . The activation of CFTR transcription by cAMP correlates with increasing sensitivity to DNase I overlapping the Y-box element (12) . This may reflect the role of trans-acting factors in modifying local chromatin structure. Although it has been shown previously that individual members of bZIP families of transcription factors have the capacity to bind and activate CFTR transcription (12, 13) , little is known about the parameters and proteins involved in directing transcription of the CFTR in vivo.
Histone modification plays an important role in regulating gene transcription (15, 16) . The level of acetylation of conserved residues on the core histones H3 and H4 appears to plays a critical role in the regulation of gene transcription (17) , and the presence of histone acetyltransferase activity correlates with the activation of other genes (18, 19) . Conversely, it is believed that gene repression is associated with the increased activity of histone deacetylases (17, 20) . Although it is accepted that histone acetyltransferases and deacetylases are tightly associated with transcriptional machinery through several well characterized transcriptional cofactors or adaptor proteins (21) (22) (23) , little is known about how such activities are directed to a specific gene. Several genes encoding histone acetyltransferase and deacetylase activities have been identified in human. Interestingly, many of these genes encode both transcriptional coactivators and corepressors, such as hGCN5, P/CAF, p300/CBP, TAF250, and HDAC1/2 (for review see Ref. 18) . Recent observations have suggested that transcriptional cofactors such as p300/CBP and HDAC1/2 encode proteins for the enzymatic histone acetyltransferase and deacetylase activities, respectively (22, 24) . These proteins can form complexes with sequence-specific nuclear hormone receptors and transcription factors (25) (26) (27) (28) . Although these cofactors do not possess sequence-specific DNA binding activities, a transcriptional cofactor can target a specific gene when tethered to a gene promoter through a heterologous DNA binding domain as shown previously (29) . Therefore, transcriptional cofactors may regulate the level of histone acetylation of a specific gene through interactions with sequence-specific transcription factors.
Our present objective was to identify proteins bound to the human CFTR promoter through the Y-box nucleotide consensus of the CFTR. We have now identified two such proteins: CDP/cut, a homeodomain repressor, and the transcription factor complex CBF⅐NF-Y. CBF⅐NF-Y is a highly conserved complex of heterotrimeric subunits shown to interact with CCAAT sequence elements common to many eukaryotic promoters (30, 31) . Conserved residues within subunits of the CBF⅐NF-Y complex, which include a region homologous to the histone-fold motif found in histones H2A and H2B, are necessary for subunit interaction to form the heterotrimeric complex (32) . Domains of CBF⅐NF-Y, located in two of the subunits (CBF-c and CBF-b) are necessary for the transactivation by the CBF⅐NF-Y complex (33) . The CBF⅐NF-Y-bound complex can form tight interactions with known histone acetyltransferases hGCN5 and P/CAF to transactivate transcription (27) . Mammalian CCAAT displacement protein/cut (CDP/cut) repressor is a 180 -190-kDa polypeptide (34 -36) closely related to the cut protein of Drosophila (37) , which determines cell fate in Drosophila (38, 39) . CDP was first described as a CCAAT-boxbinding protein in the sea urchin sperm histone promoter (40) . It was defined subsequently as a gene-specific transcriptional repressor associated with the differential regulation of the gp91 phox gene in myeloid cell differentiation (41) . Human CDP/ cut also binds to promoters of the c-myc, N-cam, thymidine kinase, c-mos, and histone genes in a variety of cell types (42) (43) (44) (45) (46) and is implicated in the regulation of gene transcription through sequence elements associated with nuclear matrix attachment (47) . The competing activities between CBF⅐NF-Y and CDP/cut have been postulated as a mechanism to regulate several genes through the CCAAT motif (44, 48, 49) .
The objective of this study was to determine further whether transcription of CFTR is regulated by nuclear factors associated with histone acetylation. Because the regulation CFTR transcription is potentiated through cAMP and the CREB/ATF activators (12, 13), we postulate that mechanisms directing the recruitment of histone acetyltransferase coactivators could, conversely, direct a histone deacetylase complex through a separate set of CCAAT-binding factors within the context of the human CFTR promoter Y-box element. In this report, we present evidence that the Y-box element of the CFTR promoter is a site that intersects histone acetylation and deacetylation processes with mechanisms to modulate transcription of CFTR.
EXPERIMENTAL PROCEDURES
Cell Culture-Pancreatic carcinoma (PANC1) and histiocytic lymphoma (U937) cells were obtained from the American Type Culture Collection (Rockville, MD). PANC1 cells stably transfected with human CFTR promoter-directed human growth hormone transgenes pCF197wt/hGH and pCF-197⌬CCAAT/hGH and the pØGH promoterless vector have been described (12) . All PANC1 cell cultures were maintained in Dulbecco's modified Eagle's medium in glucose (4.5 g/liter) (Life Technologies, Inc.). U937 cell were maintained in RPMI. Medium was supplemented with 10% fetal calf serum (Hyclone, Logan, UT) and 1 ϫ gentamycin (Life Technologies, Inc.). Cell cultures were maintained in 5% CO 2 incubator at 37°C.
Expression Plasmids-Plasmids for hGCN5 (50) (Dr. Yoshihiro Nakatani, NIH, Bethesda, MD) and ATF-1 (51) (Dr. Michael Green, University of Massachusetts, Amherst) cDNAs were generously provided as gifts. Fragments containing cDNAs were amplified by polymerase chain reaction (PCR) using primers carrying BamHI adaptors and subcloned into a mammalian expression plasmid pAsc.CMV-SVneoVA. 2 The expression of ATF-1 and hGCN5 cDNAs was directed by a cytomegalovirus immediate-early promoter in plasmid pAsc.CMV-SVneoVa. The expression vector for full-length human CDP/cut, pMT2-CDP, was described previously (34) as well as the bacterial expression plasmids for pGEXcut3-HD, pGEXcut3-term, and pGEXcut3ϩHD-term (35) . Expression and purification of CDP/cut fragments by subcloning into the pGEX2TK vector (Amersham Pharmacia Biotech) and expression in Escherichia coli bacterial strain BL-21 as glutathione S-transferase (GST) fusion proteins were as described previously (12) .
Cell Transfections and Reporter Gene Analysis-Cells were plated at a density of 5 ϫ 10 5 cells/35-mm plate (approximately 75% confluent) 18 h prior to transient transfections. Transfections were carried out as described previously (12) . Briefly, plasmid expression reporter and 100 ng of internal control pRSV/CAT were diluted to a final volume of 50 l in 20 mM Hepes buffer, pH 7.6. The DNA mixture was transferred to a tube containing 30 l of LipofectAMINE (Life Technologies, Inc.) diluted in 1 ml of Opti-MEM (Life Technologies, Inc.). The mixture was incubated for 15 min at room temperature. This medium mixture was used to replace the existing medium in the cell cultures and rocked gently, briefly, for even distribution of the mixture. Transfected cells were incubated for 6 h at 37°C in a 5% CO 2 atmosphere. At this time, medium was replaced with fresh culture medium and cultured for an additional 48 h before assaying the cultures and culture medium for chloramphenicol acetyltransferase activity and human growth hormone (hGH) (12) . The levels of hGH secreted into the medium from transfected cells were assayed by hGH enzyme-linked immunosorbent assay (Boehringer Mannheim) according to the manufacturer's instructions. hGH expression was normalized to the level of chloramphenicol acetyltransferase expression directed by the Rous sarcoma virus long terminal repeat sequences in each experiment.
Preparation of Nuclear Extracts, Electrophoretic Mobility Shift Assays, and DNase I Protection Assay-Nuclear extracts from human PANC1 cells were prepared essentially as described (52) with modifications to the preparation of nuclear extracts described previously (12) . The extracts were frozen under liquid N 2 and stored at Ϫ80°C until further use. The concentrations of the nuclear extracts were determined by colorimetric quantitation assays according to the manufacturer's directions (Bio-Rad). The double-stranded oligonucleotide corresponding to sequences of the CFTR inverted CCAAT element 5Ј-tggggggaattggaagccaaatgacatcac-3Ј was synthesized and labeled at the 5Ј-end by incubating with [␥-32 P]ATP and T4 polynucleotide kinase. The binding reactions were carried out at 4°C for 30 min with 0.1 ng of the 32 Plabeled oligonucleotide, 0.5 g of nonspecific competitor DNA (poly(dI⅐dC)), and either 2 or 10 g of PANC1 nuclear extract in the following buffer conditions: 20 mM Hepes, pH 7.9, 60 mM KCl, 0.1 mM EDTA, 5% (v/v) glycerol. For competition experiments, unlabeled competitor oligonucleotides corresponding to nucleotide sequences of the CFTR gene promoter bearing a mutant inverted CCAAT element (5Ј-tggggggaagaagccaaatgacatcac-3Ј) and mutant (5Ј-tggggggaattggaagccaaataacatgac-3Ј) were added in 100 ϫ molar excess to the binding reactions prior to the introduction of labeled oligonucleotides. All DNAprotein complexes were resolved by electrophoresis on 5% polyacrylamide:bisacrylamide (80:1) in 0.25 Tris acetate and EDTA at 10 volts/cm at 4°C. Antibody supershift assays were performed similarly, with the exception that polyclonal antiserum (1 g) to CBF-c (33), CDP/cut, or preimmune serum was added along with bovine serum albumin (5 g) directly to the DNA-nuclear extract mixture and allowed to incubate at 4°C for an additional 30 min. DNA-protein and antibody complexes were fractionated on 5% polyacrylamide:bisacrylamide (80:1) in 0.25 Tris acetate and EDTA at 10 volts/cm at 4°C.
Deoxyribonuclease I (DNase I) protection assay was performed using nuclear extracts prepared from untreated and 8-Br-cAMP-treated cells on the 127-bp fragment from the region of the CFTR promoter between Ϫ198 and Ϫ71 upstream of the translation start site. A DNA fragment was generated with the primers 5Ј-gggcagtgaaggcgggggaaagagc-3Ј and 5Ј-ctgggtgcctgccgctcaaccctt-3Ј. The 5Ј-oligonucleotide 5Ј-gggcagtgaaggcgggggaaaga-3Ј was labeled by using [␥-
32 P]ATP and T4 polynucleotide kinase. Addition of the [␥-
32 P]ATP-labeled oligonucleotide (ϳ 5 pmol) to the PCR was used to generate a 32 P-labeled DNA fragment. The DNA fragment was excised and purified from a 5% polyacrylamide gel. DNase protection experiments were carried out as described previously (12) . To confirm the location of protection from DNase hydrolysis, corresponding Maxam-Gilbert [G ϩA] reactions were conducted on the 32 P-labeled DNA fragment. Endonuclease Sensitivity Assays-Nuclei from trichostatin A (TSA)-treated, 8-Br-cAMP/TSA-treated, and untreated PANC1 cells were digested with BspMI (500 units, New England Biolabs, Beverly, MA) at 37°C for 2 h in digestion buffer (10 mM Tris-HCl, pH 7.4, 50 mM NaCl, 60 mM KCl, 0.1 mM EDTA, 5 mM MgCl 2 , 5% (v/v) glycerol, and 0.5 mM dithiothreitol). After digestion with BspMI in vivo, DNA was extracted with a phenol/chloroform/isoamyl alcohol (24:24:1) mixture and recovered by ethanol precipitation. Extracted DNA was digested further with the restriction enzymes HindIII and Eae1, fractionated on 1.8% agarose gels by electrophoresis, and transferred onto nylon membrane filters. Filters were hybridized to a 32 P-labeled DNA probe as indicated. Filters were washed three times using high stringency washing conditions with a final wash (0.1 ϫ SSC at 68°C) for 15 min. Filters were exposed to x-ray film or evaluated with a Storm 860 PhosphoImager using ImageQuant software (Molecular Dynamics, Sunnyvale, CA).
Genomic DNase I Hypersensitivity Assays-Cells were treated with 100 ng/ml TSA (Sigma) for 30 min at 37°C prior to assays. Nuclei (20 g of DNA equivalent) from stably transfected PANC1 cells (12) were treated with the addition of the RNase-free DNase I (Promega, Madison, WI) with increasing concentrations from 5 to 50 units in a buffer. Nuclease reactions were terminated by the extraction of genomic DNA with phenol/chloroform, and DNA was then precipitated with ethanol at Ϫ20°C from 2 h. DNase-treated treated DNA was digested with SacII (420 units) and SacI (340 units, New England Biolabs) at 37°C for 18 h in a 1°C digestion buffer. Digested genomic DNA was fractionated by agarose gel electrophoresis, blotted onto membranes, and hybridized to a human genomic CFTR 32 P-labeled SacII-SacI probe, indicated in the experiment shown, washed, and autoradiographed.
Immunoprecipitations and GST Pull-down Assay-U937 cells were metabolically labeled with [
35 S]methionine/cysteine (NEN Life Science Products). Nuclear lysates of 35 S-labeled U937 cells were precleared with rabbit preimmune serum and immunoprecipitated with protein A-Sepharose (Amersham Pharmacia Biotech). The remaining supernatant was used for immunoprecipitation experiments. Immunoprecipitation of HDAC1 was performed using nuclear lysates from metabolically 35 S-labeled U937 cells pretreated with GST to eliminate background and immunoprecipitated with HDAC1 antiserum (Santa Cruz Biotechnology, Santa Cruz, CA) as described (53) . The GST and the GST-CDP fusion proteins were expressed as described above and conjugated to glutathione-Sepharose beads (Amersham Pharmacia Biotech) after low stringency washing procedure (54) . The GST and GST-CDP/cut fusion proteins, bound to conjugated glutathione-Sepharose beads, were equilibrated in a lysis washing (LW) buffer (10 mM Tris-HCl, pH 7.6, 150 mM NaCl, 0.5 mM EDTA, 10 mM Na 3 (PO 4 ), 10 mM NaF, 2.5 mM leupeptin, 10 mM phenylmethylsulfonyl fluoride, 100 g of aprotinin), then incubated with nuclear extracts of 35 S-labeled U937 cells (2 ϫ 10 5 dpm) in a final volume of 250 l for 3 h at 4°C. Then the beads were centrifuged and washed three times in LW buffer and treated with HDAC1 antiserum. The antiserum was passed over a GST column to preclear anti-GST antibodies. After elution of GST fusion protein from the beads with glutathione, immunoprecipitations with HDAC1 antiserum were performed as described below. Mixtures were washed twice with LW buffer containing 0.5% deoxycholate and immunoprecipitated with protein A-Sepharose beads. The immunoprecipitates were washed three times with LW buffer containing 0.5% deoxycholate, resuspended in a 2 ϫ Laemmli gel loading buffer, and loaded onto a 12% SDS-polyacrylamide gel. Rabbit polyclonal antibodies for CDP/cut were generated against the GST fusion containing the human CDP/cut protein encoding the homeodomain through the carboxyl (COOH)-terminal region using standard protocols (54) .
In Vitro Protein-Protein Binding Assays-The GST and the GST-CDP/cut fusion proteins were expressed as described above and immobilized on glutathione-conjugated beads, washed, and equilibrated in HEKG binding buffer (40 mM Hepes, pH 7.9, 50 mM KCl, 0.2 mM EDTA, 2.5 mM leupeptin, 10 mM phenylmethylsulfonyl fluoride, 100 g of aprotinin, 1.0 mM dithiothreitol, and 0.5 mg of bovine serum albumin). Transcription template for HDAC1 was created by the reverse transcription PCR method with 0.5 g of human HeLa cell mRNA using a primer pair set corresponding to the translational open reading frame (5Ј-cgagcaagatggcgcagacgcag-3Ј) and terminus (5Ј-cgtgagggactcagcaggaagcc-3Ј) of human HDAC1. The correct PCR product was obtained, verified by gel electrophoresis and nucleotide sequence analysis, and then cloned into the vector pCR ® -Blunt according to the manufacturer's instructions (Invitrogen) to generate the in vitro transcription template pHDAC1-T7. The 35 S-labeled HDAC1 protein was synthesized in vitro from the linearized plasmid template by the use of the coupled transcription-translation system (TNT ® system, Promega). The 35 S-labeled HDAC1 protein was incubated with a 50% slurry of the corresponding GST-CDP/cut fusion protein in 400 l of HEKG binding buffer for 1 h at 4°C with gentle rocking. The Sepharose beads were then washed four times with 1 ml each time of HEKG binding buffer (lacking bovine serum albumin, leupeptin, aprotinin, and phenylmethylsulfonyl fluoride). Bound proteins were eluted in 25 l of 50 mM Tris-HCl, pH 6.9, 0.1 mM EDTA, containing 100 mM glutathione (Sigma). Eluted proteins were resuspended in a 2 ϫ Laemmli gel loading buffer and loaded onto a 12% SDS-polyacrylamide gel and resolved by electrophoresis.
In Vitro Histone Deacetylase Assays-Histone deacetylase activity was assayed essentially as described (23) with 50 l of crude cell extract, then immunoprecipitated with rabbit polyclonal antiserum against recombinant human CDP/cut (34) for 2.5 h at 37°C. Immunoprecipitates of human CDP/cut were washed three times at 4°C in a low stringent wash containing 0.1% Nonidet P-40 in phosphate-buffered saline. Pretreatment of immunoprecipitates with 100 ng/ml TSA occurred for 30 min at 4°C before addition of the peptide substrate. The synthetic peptide substrate was purchased commercially (Accurate Chemical, Westbury, NY) and corresponds to the first 24 residues of the amino-terminal domain of bovine histone H4 (23) . Immunoprecipitates were then incubated with 2.5 mg (60,000 dpm) of acid-soluble peptide for 30 min at 37°C. The reaction was terminated with acetic acid and HCl. Released [ 3 H]acetic acid was obtained by extraction with ethyl acetate and quantitated by liquid scintillation counting. Samples were were assayed triplicate (in four trials), and the nonenzymatic release of label was subtracted to obtain the final value.
RESULTS

CBF⅐NF-Y Is Associated with the CFTR Gene Proximal Y-box
Element-Because basal and cAMP-mediated CFTR transcription requires the conservation of the inverted CCAAT motif in the promoter of CFTR (12, 13) and is a potential consensus to bind CBF⅐NF-Y (55), we reasoned that CBF⅐NF-Y or similar CCAAT-binding factors could have a role in directing CFTR transcription. To identify the nuclear proteins associated with basal and inducible activation of CFTR transcription, we tested whether the transcription factor CBF⅐NF-Y complex could bind to the proximal Y-box consensus site of the human CFTR promoter. Fig. 1A demonstrates the binding of nuclear protein prepared from confluent monolayers of PANC1 cells in competitive EMSA in the presence of unlabeled competing oligonucleotides corresponding to wild-type human CFTR sequences or mutant CFTR oligonucleotide sequences. The unlabeled homologous CFTR Y-box element sequence depletes the visible complex in a competition assay. Addition of an oligonucleotide corresponding to the same sequence with the exception of a three-nucleotide deletion directed at the ATTGG to A-G failed to compete for binding. Moreover, a mutation introduced into a CRE consensus 11 bp downstream of the ATTGG sequence competed equally as well for the binding of nuclear protein from PANC1 cells ( (Fig. 1B) . This result confirms that CBF⅐NF-Y can bind the Y-box sequence of human CFTR and correlates with the relative consensus necessary for binding CBF⅐NF-Y (55). It is important to note that previous studies by this laboratory have also documented the ability of this site to bind C/EBP (12) . Antibodies directed against the C/EBP␤ and C/EBP␦ proteins alter complex formation in these experiments (data not shown) as well as in other experiments (12) but failed to immunoprecipitate any histone acetyltransferase activity. 3 However, the question that still remains is whether cell type specificity plays a role in the ability of either CBF⅐NF-Y or C/EBP to bind the CFTR Y-box element to activate transcription in vivo. Here we addressed the role of CBF⅐NF-Y to bind the CFTR promoter because of the purported role of CBF⅐NF-Y in histone acetylation (27, 28) . Therefore, we wanted to expand our studies to include other relevant DNA-binding proteins to act through the inverted CCAAT element.
Activation of CFTR Transcription by the Transcription Factor ATF-1 and the Histone Acetyltransferase hGCN5-
The correlation between the DNA-binding proteins of the Y-box element with the local structural changes in chromatin (12) has prompted speculation that the modification of core histones, which overlap the Y-box, may reflect a change to chromatin structure favorable for the activation of transcription (27, 28) . As a way of determining the role of transcription factors and chromatin accessory factors associated with the proximal Y-box (inverted CCAAT) element to influence the transcription of CFTR, transactivation assays were performed on PANC1 cells carrying stably transfected CFTR promoter-directed transgenes. Clonal populations of stably transfected cells bearing wild-type (pCF-197wt/hGH-PANC1) and mutated Y-box (pCF-197⌬CCAAT/hGH-PANC1) transgenes were used to assess the ability of cotransfected effector genes to alter expression of the integrated reporter gene. Six individual stably transfected PANC1 clonal populations were isolated and tested for each of the two transgene constructs (pCF-197wt/hGH-PANC1 and pCF-197⌬CCAAT/hGH-PANC1) to confirm that repression is not the result of integration artifacts of the two stably transfected transgenes (Fig. 2) . The background expression of promoter function was determined by including stably transfected PANC1 cells bearing the parental hGH reporter gene construct lacking a promoter (Fig. 2) . The cDNAs tested include the cyclic AMP-responsive transcription factor ATF-1 and the human histone acetyltransferase hGCN5 and activate transcription of CFTR in pancreatic carcinoma cells (Fig. 2) . Analysis of reporter transgene expression (Fig. 2) indicates that both ATF-1 and hGCN5 direct the activation of a CFTR-directed reporter gene. The observed 4 -5-fold activation was dependent on an intact Y-box element consensus site, suggesting that both ATF-1 and hGCN5 functionally converge on the Y-box element to stimulate CFTR transcription. Although the histone acetyltransferase P/CAF (56), a close homolog of hGCN5, was not tested here, similar results have been obtained from other studies (28) , suggesting the involvement of histone acetyltransferase in the activation of CFTR. A mutated CFTR Y-box element failed to confer activation by either ATF-1 or hGCN5, suggesting that the activity by each of the effectors tested requires the intact Y-box sequence. These data support the role of histone acetyltransferase in the activation of CFTR and the requirement for an intact CCAAT consensus in response to the transient expression of histone acetyltransferase activity in the PANC1 cell type.
The Human Transcriptional Repressor CDP/cut Binds to the Y-box Region of the CFTR Promoter-We had previously suggested a strong correlation between the Y-box (inverted CCAAT) element of the CFTR promoter and repression of CFTR transcription (12) . Previous experiments had demonstrated the absence of protein binding with the induction of CFTR transcription by cAMP (12) . Although repression of CFTR transcription could not be confirmed by site-directed mutagenesis because of the intrinsic nature of the inverted CCAAT in basal transcription (12) , other reports suggest that the Y-box element of CFTR could be a target for CDP/cut (44, 48) . To determine the functional role of CDP/cut in CFTR transcription, PANC1 cell clones (pCF-197wt/hGH-PANC1 and pCF-197⌬CCAAT/hGH-PANC1) were cotransfected with an ex-3 M. J. Walsh, unpublished data. pression vector encoding the full-length CDP/cut cDNA, pMT2-CDP (Fig. 3) . Because of the lack of CDP/cut protein in PANC1 cells compared with U937 cells by Western blot analysis (data not shown), PANC1 cells provided the opportunity to introduce the ectopic expression of CDP/cut in a relatively naïve model. Results (Fig. 3) demonstrate that the function of CDP/cut was dependent on the Y-box to repress activation, mediated by either ATF-1 or the human histone acetyltransferase hGCN5. Although repression of a constitutively expressed CFTR-directed transgene was relative, a striking reduction (20-fold) in hGH expression was apparent when either ATF-1 or hGCN5 was used as an activator in the cotransfection experiments (Fig. 3) . It is apparent that overexpression of CDP/cut can directly antagonize either ATF-1 or hGCN5, and repression of the constitutive expression of CFTR was consistent with the antagonism of ATF-1 and hGCN5 transactivation, as similarly reported with heterologous promoters (57). To determine if the behavior of CDP/cut to repress the activity by either ATF-1 or hGCN5 is stoichiometric, we titered the amount of the plasmid expression vector for CDP/cut, pMT2/ CDP/cut used in each cotransfection experiment (Fig. 4) . In these experiments the cell line pCF-197wt/hGH-PANC1, bearing the wild-type Y-box motif of CFTR, was used to determine the ability of CDP/cut to compete with the transactivation potential ATF-1 and hGCN5. Results shown in Fig. 4 demonstrate that the transfected CDP/cut expression vector competes in a dose-dependent manner with hGCN5 and to a lesser degree ATF-1.
To confirm whether CDP/cut does bind the CFTR promoter, studies were conducted using nuclear extracts from U937 cells and recombinant CDP/cut to determine the binding pattern of CDP/cut to the Y-box consensus site of CFTR. Results in Fig.  5A show an EMSA antibody supershift experiment performed using an oligonucleotide corresponding to a CFTR inverted CCAAT sequence (Y-box) and antibodies generated against the CDP/cut protein and a recombinant GST fusion protein of CDP/cut expressed in E. coli (see "Experimental Procedures"). Results shown in Fig. 5A indicate that CDP/cut is a component A GST-CDP/cut fusion protein carrying the third cut repeat through the termination of human CDP/cut, which includes the homeodomain, was expressed in E. coli as a GST fusion protein and used in DNase I footprint analysis (Fig. 5B) . The GST-CDP/cut fusion protein was able to confer protection of the same region overlapping the Y-box motif of the CFTR promoter (Fig. 5B) .
Inhibition of Histone Deacetylase Activity by TSA Corresponds with Activation of CFTR Transcription Mediated through the Proximal Y-box Element-
The recent findings that coactivators and transcription factors, such as p300/CBP, C/EBP, and CBF⅐NF-Y, encode or are tethered to enzymatic activity associated with histone acetylation provide rationale for investigating whether local chromatin, overlapping the Ybox, may be a direct target for histone acetylation. To test this hypothesis, we demonstrate a relationship between histone acetylation and transcription of CFTR. TSA is a specific inhibitor of histone deacetylase activity and has been associated with potentiating gene transcription in cell cultures (58, 59) . We determined the relationship of TSA treatment in multiple populations of stably transfected cells to the stimulation of reporter gene expression when directed by the human wildtype CFTR promoter. Results of our preliminary studies indicate that administration of TSA potentiates the expression of the hGH reporter gene and that potentiation of a CFTR-directed transgene specifically requires the Y-box consensus (Fig.  6 ). To investigate whether transcription, potentiated by TSA, is mediated through the Y-box motif, we then tested a stably transfected transgene in which the Y-box was mutated and no longer bound nuclear protein (12) . In the transgene constructs shown in Fig. 6 , the Y-box was either left intact in the wild-type CFTR promoter or mutated by the deletion of four nucleotides in the Y-box element. The control reporter transgene with the intact Y-box responded positively to both cAMP and TSA induction. As anticipated the reporter with the mutated Y-box sequence was not activated by either cAMP or TSA. These results indicate that TSA enhances transcription through the Y-box. Therefore, the inhibition of histone deacetylase activity is directed through interactions with the Y-box sequence of CFTR.
Inhibition of Histone Deacetylase Activity Is Associated with Chromatin Accessibility of CFTR in Vivo-
To establish a correlation between the inhibition of histone deacetylation with increased accessibility in the CFTR promoter in vivo, we examined whether TSA treatment alters the sensitivity of nuclei to hydrolysis with a restriction endonuclease. The experimental strategy was based on the ability to detect the sensitivity of the CFTR promoter in nuclei to endonuclease digestion after treatment with the histone deacetylase inhibitor, TSA. BspMI was chosen (Fig. 7B ) because it recognizes a nucleotide sequence immediately adjacent to the Y-box of the CFTR promoter. PANC1 cells, treated with TSA, were used to prepare nuclei and digested with BspMI in vivo, DNA was purified, restricted with HindIII and Eae1, and then digestion products were detected by Southern blot hybridization using a 32 P-labeled probe corresponding to the HindIII/Eae1 fragment of the CFTR promoter. Fig. 7A shows that both TSA-treated and cAMPϩTSA-treated cells display a specific pattern that corresponds with the digestion by BspMI endonuclease. This pattern demonstrates the presence of the 673-bp and 180-bp fragments shown (Fig. 7A) . Decreasing the amount of TSA, added to PANC1 cell cultures, reflects the loss of specific BspMI cleavage. The treatment of PANC1 cells with both 8-Br-cAMP and TSA (100 ng/ml) complemented the sensitivity to BspMI cleavage. Thus, TSA by itself and in combination with 8-Br-cAMP directs BspMI cleavage of nucleotide sequences adjacent to the Y-box of CFTR, suggesting that histone acetylation contributes to an alteration of chromatin structure proximal to the Y-box element of the CFTR promoter.
DNase I Hypersensitivity in the CFTR Promoter Requires an Intact Proximal Y-box Element-Because the status of histone acetylation may determine the structure of chromatin, we examined whether increased sensitivity to DNase I hydrolysis gives a pattern consistent with the stimulation of CFTR transcription. The experiment shown in Fig. 8 examined whether mutation to the intact Y-box element alters sensitivity to nuclease hydrolysis surrounding the CFTR promoter/hGH gene junction from a stably transfected transgene. Nuclei from multiple clonal populations of stably transfected pancreatic carci- noma PANC1 cell lines were pooled and used to determine whether a mutation directed at the Y-box sequence alters the pattern of nuclease sensitivity consistent with the treatment with TSA. Shown is an autoradiograph of a Southern blot hybridization (Fig. 8) depicting the relationship of an intact Y-box to DNase I hydrolysis of nuclei after treatment with TSA and cAMP. The top panels demonstrate a stably transfected PANC1 cell line, pCF-197wt/hGH-PANC1, bearing the intact wild-type Y-box sequence of the human CFTR-directed transgene (Fig. 8) . In the comparative experiment, mutation directed at the Y-box nucleotide consensus in cell line pCF-197⌬CCAAT/hGH-PANC1 failed to confer the same sensitivity to DNase I hydrolysis after treatments with either cAMP or TSA. Experiments were also performed in the absence of both TSA and cAMP in each of the transgenic constructs and demonstrate a pattern corresponding to the lack of DNase I hypersensitivity within the CFTR promoter (not shown). Although this is consistent with the activation of CFTR transcription, the comparison that is made in this experiment was planned only to reflect differences between wild-type and mutant sequences of the inverted CCAAT element. Therefore, results shown in Fig. 8 suggest that increased sensitivity to DNase I by cAMP or TSA is dependent on the intact Y-box sequence. Our results suggest that the intact inverted CCAAT sequence regulates the accessibility of chromatin after treatment with TSA and cAMP. This observation is consistent with the induction of the activation of gene transcription (shown in Fig. 6 ) and accessibilty of chromatin to BspMI cleavage (shown in Fig. 7) . We support the notion that the acetylation of histones, mediated by the CCAAT sequence element, contributes to the activation of CFTR-directed transcription. However, we do not know the precise mechanism for this result, nor do we suggest that CBF⅐NF-Y (or other CCAAT-binding factor) is responsible for the targeted recruitment of histone acetyltransferase activity to CFTR. We observed that DNase I hypersensitivity may correlate closely with the accessibility of the sequences in chromatin by potential trans-acting factors. Access to the CCAAT element in chromatin may be stimulated further by histone acetylation, and this, in turn, potentiates further remodeling of chromatin through the association of histone acetyltransferases consistent with other findings (27, 28) .
HDAC1 Is Associated with the COOH-terminal Region of CDP/cut-Recent observations have shown that repressors of transcription alter chromatin structure through the association of histone deacetylase activities (60, 61) . Studies also have shown the association of a novel mammalian transcriptional corepressor, mSin3A, with the histone deacetylases HDAC1 and HDAC2 (23, 60) . Interactions are mediated through a paired amphipathic helix domain conserved within several proteins and associated with protein-protein interactions (60 -62) . We tested the hypothesis to determine if human CDP/cut, which binds to the Y-box of the CFTR, may recruit the interactions of a histone deacetylase through a domain similar to the paired amphipathic helix motif of mSin3A (57, 60) . To determine if histone deacetylase activity was associated with CDP/cut in vivo histone deacetylase activity was tested on immunoprecipitates of CDP/cut as shown in Fig. 9A . CDP/cut immunoprecipitates possess histone deacetylase activity when using a synthetic peptide substrate corresponding to the first 24 amino-terminal residues of histone H4 (23) . However, only background levels of histone deacetylase activity were detected in the immunoprecipitates when the antiserum was blocked with the specific immunogen, recombinant CDP/cut. To determine if the deacetylase activity is present, as described in Figs. 6 and 7, we tested whether TSA would inhibit the activity associated with the immunoprecipitates of CDP/cut. Results show that treatment of the immunoprecipitates of CDP/cut with TSA reduces the acetylation by approximately 60 -70% (Fig. 9A ). This suggests that the associated histone deacetylase activity in the CDP/cut immunoprecipitates is sensitive to TSA treatment. Using a truncated human CDP/cut corresponding to the carboxyl-terminal region of human CDP/cut, we generated three GST fusion proteins representative of the carboxyl terminus of CDP/cut (shown in Fig. 9B ). Previous studies have shown that the repressor function of CDP/cut was confined to the COOH-terminal region of the CDP/cut gene product (57) . In the experiment shown in Fig. 9C , GST fusion proteins were expressed and purified. Proteins shown in Fig. 9C correspond to the regions of human CDP/cut which encode fusion proteins overlapping the homeodomain through the end of CDP/cut, the cut3 domain to the COOH-terminal end of CDP/cut, and the cut3 through the homeodomain shown as GST-CDP/cut (HDterm), GST-CDP/cut (cut3-term), and GST-CDP/cut (cut3-HD), respectively. Each of these GST-CDP/cut fusion proteins was used as a target to attract interactions to the COOHterminal third of CDP/cut of extracts from U937 cells metabolically labeled with [ 35 S]methionine/cysteine, followed by the GST pull-down assay with glutathione-agarose beads. The 35 Slabeled protein complexes, bound to the GST-CDP/cut fusion proteins, were precipitated with glutathione-conjugated agarose and then characterized by immunoprecipitation with a rabbit polyclonal antibody directed against HDAC1 fusion protein (Fig. 9B) . The polyclonal antibody and 35 S-labeled protein extracts were preabsorbed with recombinant GST protein prior to the immunoprecipitation. Results of the immunoprecipitation experiment (Fig. 9D) show the association of the recombinant CDP/cut fusion protein with HDAC1 (55 kDa) (60, 61) as the candidate protein indicated in Fig. 9D . Immunoprecipitation of 35 S-labeled extracts is shown in the first lane and indicates the immunoprecipitation of HDAC1 from protein extracts of U937 cells as well as two consistent bands corresponding to molecular masses of 150 and 50 kDa.
Interaction of GST-CDP with HDAC1 in Vitro-Studies described above suggest that 35 S-labeled HDAC1, from metabolically radiolabeled U937 cells, is somehow tethered to CDP (Fig. 9) . To confirm whether the interaction between GST-CDP and HDAC1 is a result of a direct interaction or mediated by other factors (i.e. mSin3A or mSin3B) we examined the nature of the interaction in vitro. We tested the ability of 35 S-labeled HDAC1, synthesized and radiolabeled in vitro using a coupled FIG. 7 . Endonuclease sensitivity of the CFTR promoter by TSA. Panel A, PANC1 cells were treated with increasing amounts of TSA (10, 100, and 250 ng/ml) or TSA (100 ng/ml) with 500 M 8-BrcAMP. Nuclei were digested with BspMI, genomic DNA was then extracted followed by digestion with HindIII and Eae1. Digested DNA was fractionated by electrophoresis, transferred to filters, and hybridized to the indicated probe. The upper most band and two lower bands represent undigested or BspMI-digested bands, respectively. In the last lane, TSA-treated nuclei were digested with BspMI, and genomic DNA was extracted and loaded on to the gel in the absence of HindIII and Eae1 digestion. Plasmid DNA, corresponding to the identical genomic region, was digested in vitro (naked DNA) and used as a control for comparison (not shown). Molecular weight DNA markers were used to confirm the length of the fragments. The lengths of undigested and digested fragments are shown to the left. kb, kilobases. Panel B, diagram of CFTR and the corresponding endonuclease digestion. The inverted CCAAT (Y-box) element is indicated as the hatched box. Double arrows indicate the anticipated fragments after digestion with BspMI. The shaded bar indicates the length of the 32 P-labeled probe used corresponding to the restriction fragment of CFTR.
transcription-translation system, to bind to different domains of CDP/cut, expressed as GST fusion proteins and immobilized on glutathione-agarose beads. The structure of full-length CDP/cut, depicted in Fig. 10A , is comprised of a single coiledcoil domain, three cut repeats, and one homeodomain in addition to the transcriptional repressor domain at the most COOH-terminal region (57) . We suggest that the repressor domain of CDP/cut recruits the interaction with HDAC1, and we sought to localize the region of CDP/cut to interact with HDAC1. Consistent with our hypothesis (Fig. 10B ) the COOHterminal end of CDP/cut, expressed as GST-CDP (cut3-term), is competent to interact with HDAC1 by this in vitro binding assay, whereas HDAC1 exhibited no binding to the GST protein control. Furthermore, truncation of the COOH-terminal region, shown as the GST-CDP (cut3-HD) protein (Fig. 10B) , impaired the ability of the fusion protein to interact with HDAC1. The GST-CDP (HD-term) construct containing the homeodomain and COOH-terminal domain maintained the interaction with HDAC1 (Fig. 10B) . DISCUSSION The architecture of chromatin plays a fundamental role in the regulation of genes. The underlying behavior of gene transcription in vivo may be determined more by the overall structure of chromatin as a result of the cumulative function transcription factors have in regulating local chromatin structure. The relationship between the remodeling of chromatin by the modification of histones and gene-specific transcription factors recently has become more apparent (15, 20) . Since the observation of transcriptional regulatory proteins encoding intrinsic activity for the acetylation or deacetylation of histones, this mechanism for altering chromatin structure has gained prominence in the study of gene regulation (19) . Although it is believed that acetylation of histones may neutralize charged lysine residues to allow for the movement or displacement of nucleosomes along a DNA template, making local chromatin more accessible and active for gene transcription, a precise mechanism for this model has yet to be elucidated.
In this report, we provide evidence that the CFTR gene Y-box element is a potential target of the CBF⅐NF-Y activation complex. This was demonstrated by competitive EMSA and supershift analysis (Fig. 1) . CBF⅐NF-Y has been implicated previously in the assembly and remodeling of chromatin structure surrounding its cognate sequence (63) . The trimeric subunit complex of CBF⅐NF-Y has been shown previously to possess histone acetyltransferase activity through the tethering of hGCN5 and/or P/CAF to CBF⅐NF-Y (27, 28) . Previously, we have also demonstrated the binding of the CFTR inverted CCAAT (Y-box) sequence by the transcription factor C/EBP (12) . Although our study here has not included the role of C/EBP on CFTR transcription, it is important to note that C/EBP can interact with CBP/p300 in vivo (64) and is the focus of other studies. We believe that C/EBP may play a particularly intriguing role in CFTR transcription. The absence of C/EBP in cell lines derived from transgenic "knockout" mice, when compared with wild-type littermates, show the lack of p300-containing complexes associated with the CFTR Y-box. However, this observation is in contrast to results showing CBP associated with the same Y-box element in both knockout and wildtype cell lines. 4 Interestingly, the rate of CFTR transcription in vivo in these same "knockout" cell lines is precisely half of that compared with the wild-type cell lines. It is plausible to consider that the composition of individual coactivator complexes could reflect a preferential stoichiometric arrangement or dosage between CBP and p300 (65) and may demonstrate some distinction and/or differential regulation between the two coactivators.
We have demonstrated that transcription of CFTR is mediated by the transcription factor ATF-1 and the human histone acetyltransferase hGCN5 (Fig. 2) . Transfection studies have demonstrated the activating potential of the transcription factor ATF-1 and the human histone acetyltransferase hGCN5 to stimulate CFTR transcription. Evidence that hGCN5 potentiates transcription of CFTR indicates a role for histone acetylation in the regulation of CFTR transcription. We also show that CDP/cut has a functional role in repressing transcription of CFTR. This result suggested to us that CDP/cut effectively competes with transcriptional activators hGCN5 and ATF-1 to antagonize directly the activation of CFTR transcription (Figs.  3 and 4) . The binding of CDP/cut (shown in Fig. 5, A and B) overlaps the Y-box of CFTR; therefore, we speculate that transcription factors bound to the Y-box may, differentially, alter the pattern of histone acetylation in chromatin proximal to transcript initiation to regulate transcription. In our studies, we have used the CDP/cut protein, from nuclear extracts, transfected COS-7 cells, and from protein expressed in bacteria to show binding to the CFTR Y-box (Fig. 5B) . How does the Y-box element function to regulate CFTR transcription in vivo? Our studies demonstrate that inhibition of histone deacetylase activity with TSA corresponds to the stimulation of CFTR transcription mediated through an inverted and intact CCAAT sequence. Evidence in this report implies that activities competing for the association with the Y-box element regulate the level of histone acetylation in chromatin surrounding the transcript start sites, leading to either activation or repression of gene transcription. We have shown that inhibition of histone deacetylase activity by TSA potentiates the transcription of a CFTR-directed transgene through the Y-box element. Thus, the activation of CFTR transcription could be linked to histone acetyltransferase activity through the inverted CCAAT nucleotide consensus (Y-box) sequence. Examination of the CFTR promoter in vivo using a BspMI endonuclease sensitivity assay suggests that TSA will promote cleavage of nucleotide sequences proximal to the CFTR Y-box element and CRE (Fig. 7) . Furthermore, DNase I hypersensitivity assays shown in Fig. 8 demonstrate that an intact 5Ј-ATTGG-3Ј sequence of human CFTR is required for DNase I hypersensitivity of nuclei. DNase I hypersensitivity of two CFTR-directed transgenic constructs reveals that, in fact, the ATTGG consensus is an essential nucleotide requirement for the nuclease hypersensitivity of the CFTR promoter in chromatin as a result of the inhibition of histone deacetylase activity in vivo. This has been demonstrated in several randomly selected stably transfected clones (data not shown). Despite the inhibition of histone deacetylase activity by TSA to stimulate CFTR transcription through the putative alteration of chromatin structure, overlapping the Y-box element, there is no direct evidence to show the modification of histones within the context of the CFTR promoter to undergo changes in acetylation patterns as a result of TSA treatment. However, our observations suggest that the specialized sensitivity of local chromatin to nuclease hydrolysis is linked to the inhibition of histone deacetylase activity. We have yet to establish whether trans-acting factors bound to the CFTR Y-box element (such as CDP/cut, C/EBP, or CBF⅐NF-Y) can target the enzymatic modification of local histones in vivo (66) . Although the correlation between histone acetylation and gene activation is established, further studies to determine the extent of local chromatin to undergo histone modification will have to be performed.
Our observations suggest the association of CDP/cut with histone deacetylase activity. We propose that transcriptional repression by CDP/cut may recruit histone deacetylases to CFTR and that certain factors tethered to the DNA-binding proteins (such as CDP/cut) can target the deacetylation (or acetylation) of specific lysine residues of core histones such as those established through similar models (67, 68) . Because CFTR transcription is potentiated through TSA we tested whether CDP/cut may function to interact with any known histone deacetylase. Immunoprecipitation of CDP/cut demonstrates that along with CDP/cut, histone deacetylase activity is coimmunoprecipitated and is inhibited by TSA. Furthermore, studies using fusion proteins of CDP/cut indicate that CDP/cut may recruit interactions with histone deacetylase, HDAC1, through the COOH-terminal domain known to contain the repression domain of CDP/cut (57) . It is only implied here that CDP/cut may repress gene transcription of CFTR through a mechanism incorporating the histone deacetylation of chromatin in proximity to the CFTR promoter. Although the molecular basis for the repression mediated by CDP/cut in vivo is not known, it could conceptually involve competition between enzymes involved in histone acetylation associated with sequence-specific transcription factors. Although this simple model could explain the role CDP/cut may have in transcriptional repression of CFTR, still little is known about the precise mechanism directing specific alterations in local chromatin domains in vivo. stoichiometric relationship between competing acetylation and deacetylation processes. Thus, the requirement for the Y-box in hGCN5-mediated transactivation of CFTR suggests that the Y-box element likely binds proteins necessary for the conformational changes in chromatin structure. There is evidence to suggest that certain transcription factors have higher affinity for their binding sites when the nucleotide sequences are embedded in chromatin assembled from hyperacetylated histones (69) . It is plausible that competing activities directed by CDP/ cut or CBF⅐NF-Y, as an example, recruit activities favorable for either the repression or activation of CFTR transcription, respectively. Although we suggest that CDP/cut recruits histone deacetylase activity, it is unclear precisely how such a ternary complex of CDP/cut is assembled in the context of the CFTR promoter Y-box element and whether such events do take place in vivo. Future studies will have to take into account the enzymatic modification of histones associated with the site of transcriptional repression (and activation) and will likely provide a more detailed model for the regulation of CFTR transcription. Investigations to determine the extent of acetylation directed at specific lysine residues within core histones H4 and H3 of local chromatin will provide important information about how such activity is targeted to the CFTR promoter. However, our observations are consistent with the role of both CBF⅐NF-Y and CDP/cut to regulate genes through the recruitment of accessory enzymatic function to enhance the effect of these factors either to activate or repress specific genes, respectively (27, 28, 57) . The recent demonstration that HDAC1 and the mSin3A transcriptional corepressor are present as a complex in vivo and physically interact (60, 61) , along with results presented here, suggests that histone deacetylase activity is targeted to the CFTR inverted CCAAT sequence by the association with the transcriptional repressor CDP/cut. A consistent pattern in the GST pull-down assay with GST-CDP/cut fusion protein (Fig. 9C) indicates bands of ϳ150 and 50 kDa, respectively; these bands closely correlate with the molecular mass of mSin3A or N-CoR and HDAC2, respectively (70) . In a model proposed for the repression of Pit-1-mediated transcription it was shown that the transcriptional repressors RPX and Msx-1, both homeodomain proteins, are tethered to mSin3A and HDAC1 through the mSin3A corepressor homolog N-CoR to repress transcription (71) . It is likely that CDP/cut, like CBF⅐NF-Y or CREB/ATF, recruits transcriptional adaptor proteins that are comprised of either coactivator or corepressor ternary complexes dependent on the factor bound to the Y-box element. For transcription factors bound to a chromatin template in both activated and repressive states of transcription this would determine the coactivator or corepressor composition. For example, the activation of CFTR transcription by ATF-1 and hGCN5 may account for the presence of a transcriptional coactivator p300/CBP-bound complex to displace further nucleosome-mediated repression of CFTR through histone acetyltransferase activity (20) . Conversely, CDP/cut bound to the Y-box of CFTR may displace the p300/CBP coactivator ternary complex in the activated state of transcription through the association with histone deacetylase activity. Therefore, the amount of CDP/cut expressed in the cell (Fig. 4) may reflect a conversion of the exposed Y-box to a less accessible element in chromatin as a result of increased recruitment of histone deacetylase activity. Thus, the absence (or displacement) of CDP/cut correlates with the ability of activating mechanisms of transcription associated with histone acetyltransferase activities to promote transcription. Although we do not preclude the role of other cis-acting regulatory elements of CFTR to promote the induction of transcription, here we indicate a correlation between the accessibility of chromatin in CFTR transcription with the intact ATTGG sequence of CFTR. Even though several mechanisms control transcription in vivo, the regulation of chromatin architecture by opposing enzymatic activities is implied here as central to this process. Therefore, the regulation of enzymatic function by histone acetylation factors could conceivably benefit those afflicted with cystic fibrosis through the enhancement of CFTR expression in cells that bear mutations conferring a mild cystic fibrosis phenotype.
